One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Editor’s Acknowledgement
doi : 10.1093/rheumatology/keac088
Rheumatology, Volume 61, Issue 5, May 2022, Pages 1739–1747
Rheumatologists have an important role in the management of interstitial lung disease (ILD): a cross-speciality, multi-centre, UK perspective
Puja Mehta, Rachel K Hoyles, Harsha Gunawardena, Bibek Gooptu, Nazia Chaudhuri, Melissa J Heightmann, Helen Garthwaite, Henry Penn, Arnab Datta, Shahir Hamdulay, Boris Lams, Sangita Agarwal, Melissa Wickremesinghe, Gisli Jenkins, Joanna C Porter, Christopher P Denton
Rituximab—a B cell targeted therapy in systemic lupus erythematosus: where do we stand?
Silvia Piantoni, Peter Korsten
Is adipose-tissue (or its fraction) grafting really effective in the treatment of scleroderma hand?
Nicoletta Del Papa, Claudio Vitali, Antonina Minniti, Roberto Caporali
Long-term treatment in rheumatoid arthritis: do biological and targeted-synthetic DMARDs increase the risk of malignancy?
Filippo Fagni, David Simon
British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy
Alexander G S Oldroyd, James B Lilleker, Tania Amin, Octavio Aragon, Katie Bechman, Verna Cuthbert, James Galloway, Patrick Gordon, William J Gregory, Harsha Gunawardena, Michael G Hanna, David Isenberg, John Jackman, Patrick D W Kiely, Polly Livermore, Pedro M Machado, Sue Maillard, Neil McHugh, Ruth Murphy, Clarissa Pilkington, Athiveeraramapandian Prabu, Phoebe Rushe, Stefan Spinty, Joanne Swan, Hasan Tahir, Sarah L Tansley, Paul Truepenny, Yvonne Truepenny, Kishore Warrier, Mark Yates, Charalampia Papadopoulou, Neil Martin, Liza McCann, Hector Chinoy,
2-deoxy-2[18F]fluoro-D-glucose positron emission tomography–computed tomography in rheumatological diseases
Manil Subesinghe, Shaheel Bhuva, Nikita Arumalla, Andrew Cope, David D’Cruz, Sujith Subesinghe
A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition
Iain B McInnes, Zoltán Szekanecz, Dennis McGonagle, Walter P Maksymowych, Alexander Pfeil, Ralph Lippe, In-Ho Song, Apinya Lertratanakul, Thierry Sornasse, Ana Biljan, Atul Deodhar
Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic
Matteo Piga, Alberto Floris, Mattia Congia, Elisabetta Chessa, Ignazio Cangemi, Alberto Cauli
Social factors and chronic pain: the modifying effect of sex in the Stockholm Public Health Cohort Study
Jesús Prego-DomÃnguez, Eva Skillgate, Nicola Orsini, Bahi Takkouche
Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice
Viking Huss, Hannah Bower, Hjalmar Wadström, Thomas Frisell, Johan Askling, the ARTIS group
Has the incidence of total joint arthroplasty in rheumatoid arthritis decreased in the era of biologics use? A population-based cohort study
Vivienne Y Zhou, Diane Lacaille, Na Lu, Jacek A Kopec, Donald S Garbuz, Yi Qian, J Antonio Aviña-Zubieta, John M Esdaile, Hui Xie
Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b/tsDMARDs: insights from 3787 cases in the FIRST registry
Koshiro Sonomoto, Hiroaki Tanaka, Tuan Manh Nguyen, Hiroko Yoshinari, Kazuhisa Nakano, Shingo Nakayamada, Yoshiya Tanaka
SM03, an anti-human CD22 monoclonal antibody, for active rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled study
Jing Li, Mengtao Li, Di Wu, Jiaxin Zhou, Shui-on Leung, Fengchun Zhang
Effects of biologics on reducing the risks of total knee replacement and total hip replacement in rheumatoid arthritis
Yu-Sheng Chang, Jin-Hua Chen, Tzu-Min Lin, Hui-Ching Hsu, Wei-Sheng Chen, Sheng-Hong Lin, Pei-I Kuo, Yi-Chun Lin, Chi-Ching Chang
The impact of statins on coronary atherosclerosis progression and long-term cardiovascular disease risk in rheumatoid arthritis
George A Karpouzas, Sarah R Ormseth, Elizabeth Hernandez, Matthew J Budoff
Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE
Maria Antonietta D’Agostino, Georg Schett, Alejandra López-Rdz, Ladislav Šenolt, Katalin Fazekas, Ruben Burgos-Vargas, Jose Maldonado-Cocco, Esperanza Naredo, Philippe Carron, Anne-Marie Duggan, Punit Goyanka, Maarten Boers, Corine Gaillez
Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study
Alexis Ogdie, Daniel B Shin, Thorvardur Jon Love, Joel M Gelfand
Incorporating gout guideline advice into urate reports is associated with reduced hospital admissions: results of an observational study
Philip L Riches, Laura Downie, Carol Thomson
Can we predict if patients with SLE will require more than one cycle of rituximab?
Raquel Fernández González, Rym Abida, Eugeniu Gisca, Leila Duarte, David A Isenberg
Relationship of anifrolumab pharmacokinetics with efficacy and safety in patients with systemic lupus erythematosus
Yen Lin Chia, Jianchun Zhang, Raj Tummala, Tomas Rouse, Richard A Furie, Eric F Morand
Impact of teleconsultation on subsequent disease activity and flares in patients with systemic lupus erythematosus
Jonathan T W Au Eong, Aisha Lateef, Shen Liang, Sandy H H Lim, Sen Hee Tay, Anselm Mak, Jiacai Cho
External validation of the Systemic Lupus International Collaborating Clinics Frailty Index as a predictor of adverse health outcomes in systemic lupus erythematosus
Alexandra Legge, Alicia Malone, John G Hanly
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients
Tommaso Schioppo, Lorenza Maria Argolini, Savino Sciascia, Francesca Pregnolato, Francesco Tamborini, Paolo Miraglia, Dario Roccatello, Renato Alberto Sinico, Roberto Caporali, Gabriella Moroni,Maria Gerosa
Adipose tissue-derived stromal vascular fraction for treating hands of patients with systemic sclerosis: a multicentre randomized trial Autologous AD-SVF versus placebo in systemic sclerosis
Aurélie Daumas, Jérémy Magalon, Elisabeth Jouve, Dominique Casanova, Cécile Philandrianos, Maxime Abellan Lopez, Stéphanie Mallet, Julie Veran, Isabelle Auquit-Auckbur, Dominique Farge, Hervé Levesque, Ygal Benhamou, Laurent Arnaud, Laurent Giraudo, Chloé Dumoulin, Camille Giverne, Olivier Boyer, Alexandra Giuliani, Véronique Bourgarel, Jean-Robert Harlé, Nicolas Schleinitz, Julie Brunet, Yves-Marie Pers, Rosanna Ferreira, Audrey Cras, David Boccara, Jérome Larghero, Joseph Château, Arnaud Hot, Françoise Dignat-George, Guy Magalon, Florence Sabatier, Brigitte Granel
Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis
Julia Spierings, Svetlana I Nihtyanova, Emma Derrett-Smith, Kristina E N Clark, Jacob M van Laar, Voon Ong, Christopher P Denton
IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-α blockers
Camille Rasmussen, Vered Abitbol, Khalil El Karoui, Anne Bourrier, Romain Paule, Lucine Vuitton, François Maurier, David Laharie, Mathurin Fuméry, Christian Agard, Michael Collins, Stephane Nancey, Cédric Rafat, Anne-Gaëlle Kervegant, Viviane Queyrel-Moranne, Guillaume Moulis, Bénédicte Pigneur, Alexis Régent, Claire Gay, Caroline Morbieu, Cécile Audrey Durel, Didier Ducloux, François Aubin, Mickaela Voicu, Nizar Joher, Tali Szwebel, Christine Martinez-Vinson, Stéphane Koch, Loïc Guillevin, Laurent Peyrin-Biroulet, Benjamin Terrier
Utility of interval kidney biopsy in ANCA-associated vasculitis
Gavin B Chapman, Tariq E Farrah, Fiona A Chapman, Dan Pugh, Christopher O C Bellamy, Rashmi Lahiri, Eve Miller-Hodges, David C Kluth, Robert W Hunter, Neeraj Dhaun
Causes of Raynaud’s phenomenon and the predictive laboratory and capillaroscopy features for the evolution to a definite connective tissue disease
Saeedeh Shenavandeh, Mehrnoush Ajri, Sahand Hamidi
Comparison of salivary gland MRI and ultrasonography findings among patients with Sjögren’s syndrome over a wide age range
Yukinori Takagi, Miho Sasaki, Sato Eida, Ikuo Katayama, Kunio Hashimoto, Hideki Nakamura, Toshimasa Shimizu, Shimpei Morimoto, Atsushi Kawakami, Misa Sumi
Glucocorticoid dosing and relapses in giant cell arteritis—a single centre cohort study
Laura Felten, Nicolai Leuchten, Martin Aringer
Nailfold capillaries and myositis-specific antibodies in anti–melanoma differentiation–associated gene 5 antibody-positive dermatomyositis
Tomohiro Sugimoto, Sho Mokuda, Hiroki Kohno, Michinori Ishitoku, Kei Araki, Hirofumi Watanabe, Tadahiro Tokunaga, Yusuke Yoshida, Shintaro Hirata, Eiji Sugiyama
Survival and associated comorbidities in inclusion body myositis
Elie Naddaf, Shahar Shelly, Jay Mandrekar, Alanna M Chamberlain, E Matthew Hoffman, Floranne C Ernste, Teerin Liewluck
Discordance in patient and physician global assessment in relapsing polychondritis
Emily Rose, Marcela A Ferrada, Kaitlin A Quinn, Laurent Arnaud, Wendy Goodspeed, Jeff Kim, Clint Allen, Arlene Sirajuddin, Marcus Chen, Peter C Grayson
How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohort
Elena Nikiphorou, Annelies Boonen, Bruno Fautrel, Pascal Richette, Robert Landewé, Désirée van der Heijde, Sofia Ramiro
Individual-level and country-level socio-economic factors and health outcomes in spondyloarthritis: analysis of the ASAS-perSpA study
Dafne Capelusnik, Sizheng Steven Zhao, Annelies Boonen, Nelly Ziade, Clementina López Medina, Maxime Dougados, Elena Nikiphorou, Sofia Ramiro
Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis
Uta Kiltz, Annelies Boonen, Désirée van der Heijde, Wilson Bautista-Molano, Ruben Burgos Vargas, Praveena Chiowchanwisawakit, Bassel El-Zorkany, Inna Gaydukova, Pal Geher, Laure Gossec, Michele Gilio, Simeon Grazio, Jieruo Gu, Muhammad Asim Khan, Tae-Jong Kim, Walter P Maksymowych, Helena Marzo-Ortega, Victoria Navarro-Compán, Salih Ozgocmen, Dimos Patrikos, Fernando Manuel Pimentel-Santos, John Reveille, Michael Schirmer, Simon Stebbings, Filip Van den Bosch, Ulrich Weber, Juergen Braun
Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial)
Walter P Maksymowych, Mikkel Østergaard, Robert Landewé, William Barchuk, Ke Liu, Chantal Tasset, Leen Gilles, Thijs Hendrikx, Robin Besuyen, Xenofon Baraliakos
The risk, predictors and outcomes of amyloidosis in ankylosing spondylitis: a longitudinal population-based cohort study
Mouhammad Kridin, Khalaf Kridin, Arnon D Cohen, Howard Amital, Abdulla Watad
Identifying trajectories of radiographic spinal disease in ankylosing spondylitis: a 15-year follow-up study of the PSOAS cohort
Mark C Hwang, MinJae Lee, Lianne S Gensler, Matthew A Brown, Amirali Tahanan, Mohammad H Rahbar, Theresa Hunter, Mingyan Shan, Mariko L Ishimori, John D Reveille, Michael H Weisman, Thomas J Learch
Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial
Jerold Jeyaratnam, Anna Simon, Inmaculada Calvo, Tamas Constantin, Anna Shcherbina, Michael Hofer, Marco Gattorno, Alberto Martini, Brigitte Bader-Meunier, Bas Vastert, Jeremy Levy, Elise Dekker, Fabrizio de Benedetti, Joost Frenkel
Incidence of chronic immune-mediated inflammatory diseases after diagnosis with Kawasaki disease: a population-based cohort study
Stephen G Fung, Richard Webster, M Ellen Kuenzig, Braden D Knight, Michelle Batthish, Cal Robinson, Rahul Chanchlani, Eric I Benchimol, Carolina Jimenez-Rivera
Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use
Joeri W van Straalen, Roline M Krol, Gabriella Giancane, Violeta Panaviene, Laura Marinela Ailioaie, Pavla Doležalová, Marco Cattalini, Gordana Susic, Flavio R Sztajnbok, Despoina Maritsi, Tamas Constantin, Sujata Sawhney, Marite Rygg, Sheila Knupp Oliveira, Ellen Berit Nordal, Claudia Saad-Magalhães, Nadina Rubio-Perez, Marija Jelusic, Sytze de Roock, Nico M Wulffraat, Nicolino Ruperto, Joost F Swart
Morning stiffness precedes the development of rheumatoid arthritis and associates with systemic and subclinical joint inflammation in arthralgia patients
Doortje I Krijbolder, Fenne Wouters, Elise van Mulligen, Annette H M van der Helm-van Mil
Ultrasound assessment of hands and feet for synovitis at time of first clinical visit markedly reduces time to diagnosis in routine care
Mads Ammitzbøll-Danielsen, Viktoria Fana, Uffe Møller Døhn, Torsten Møller, Sin Ngai Ng, Anne Emilie Secher, Jens Jørgen Lykkegaard, Lene Terslev
IgA anti-citrullinated protein antibodies are associated with flares during DMARD tapering in rheumatoid arthritis
Maria V Sokolova, Melanie Hagen, Holger Bang, Georg Schett, Juergen Rech, Ulrike Steffen, the RETRO study group
Ageing enhances cellular immunity to myeloperoxidase and experimental anti-myeloperoxidase glomerulonephritis
Maliha A Alikhan, Juli Jaw, Lani R Shochet, Kate J Robson, Joshua D Ooi, Elisabeth Brouwer, Peter Heeringa, Stephen R Holdsworth, A Richard Kitching
Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response
Butsabong Lerkvaleekul, Saskia R Veldkamp, M Marlot van der Wal, Ellen J H Schatorjé, Sylvia S M Kamphuis, J Merlijn van den Berg, Petra C E Hissink Muller, Wineke Armbrust, Sebastiaan J Vastert, Judith Wienke, Marc H A Jansen, Annet van Royen-Kerkhof, Femke van Wijk
Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren’s syndrome
Erika Huijser, Jens Göpfert, Zana Brkic, Cornelia G van Helden-Meeuwsen, Sanne Jansen, Thomas Mandl, Peter Olsson, Benjamin Schrijver, Marco W J Schreurs, Paul L A van Daele, Willem A Dik, Marjan A Versnel
The impact of education inequality on rheumatoid arthritis risk is mediated by smoking and body mass index: Mendelian randomization study
Sizheng Steven Zhao, Michael V Holmes, Jie Zheng, Eleanor Sanderson, Alice R Carter
Identification of distinct cytokine/chemokine profiles in dermatomyositis with anti-transcriptional intermediary factor 1-γ antibody
Qian Zhao, Yongheng Chen, Licheng Diao, Shimin Zhang, Dan Wu, Feng Xue, Qunli Xia, Hao Li, Jie Zheng, Hua Cao
CXCR5/CXCL13 pathway, a key driver for migration of regulatory B10 cells, is defective in patients with rheumatoid arthritis
Claire Rempenault, Julie Mielle, Kristina Schreiber, Pierre Corbeau, Laurence Macia, Bernard Combe, Jacques Morel, Claire Immediato Daien, Rachel Audo
Phenotype, function and clinical significance of innate lymphoid cells in immunoglobulin G4–related disease
Panpan Zhang, Zheng Liu, Linyi Peng, Jiaxin Zhou, Mu Wang, Jieqiong Li, Hui Lu, Chaojun Hu, Lidan Zhao, Huaxia Yang, Qian Wang, Yunyun Fei, Xuan Zhang, Yan Zhao, Xiaofeng Zeng, Wen Zhang
Erratum to: Glucocorticoid dosing and relapses in giant cell arteritis—a single centre cohort study
Laura Felten, Nicolai Leuchten, Martin Aringer
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study
Giuseppe A Ramirez, Marco Lanzillotta, Mikael Ebbo, Andreu Fernandez-Codina, Gaia Mancuso, Olimpia Orozco-Galvez, Lorenzo Dagna, Nicolas Schleinitz, Fernando MartÃnez-Valle, Emma L Culver, Emanuel Della-Torre
Behçet’s-like adverse event or inaugural Behçet’s disease after SARS-CoV-2 mRNA-1273 vaccination?
Florian Tagini, Lionel Carrel, Benedict Fallet, David Gachoud, Camillo Ribi, Matteo Monti
Hypomorphic variant in TRNT1 induces a milder autoinflammatory disease with congenital cataracts and impaired sexual development
MarÃa Bravo GarcÃa-Morato, Beatriz Padilla-Merlano, Elisabet Matas Pérez, Juan Luis Valdivieso Shephard, Ã�ngel Robles Marhuenda, Fernando Santos Simarro, Eduardo López-Granados, Rebeca RodrÃguez Pena
Successful treatment with azacitidine in VEXAS syndrome with prominent myofasciitis
Isabell Cordts, Judith S Hecker, Darja Gauck, Joohyun Park, Johanna Härtl, Roman Günthner, Ariane Hammitzsch, Benedikt Schoser, Dietrich Abeck, Katharina S Götze, Tobias B Haack, Marcus Deschauer, Philipp Moog, Bernhard Hemmer
Comment on: Nailfold capillaries and myositis specific antibodies in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis
Shogo Matsuda, Takuya Kotani, Tohru Takeuchi
Comment on: Nailfold capillaries and myositis-specific antibodies in anti-melanoma differentiation-associated gene 5 antibody-positive DM. Reply
Tomohiro Sugimoto, Sho Mokuda, Hiroki Kohno, Michinori Ishitoku, Kei Araki, Hirofumi Watanabe, Tadahiro Tokunaga, Yusuke Yoshida, Shintaro Hirata, Eiji Sugiyama
Comment on: Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologist
Vanessa Quick, Bhaskar Dasgupta, Sarah Mackie, Chetan B Mukhtyar
Comment on: Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologist: reply
Peter M Andel, Stavros Chrysidis, Julia Geiger, Anne C Bull Haaversen, Glenn Haugeberg, Geirmund Myklebust, Berit D Nielsen, Andreas P Diamantopoulos
Spinal gout with erector spinae muscle entrapment
Gang Wang, Ning Zhuo, Feng Tian, Zhenhua Wen, Jingyang Li
An important diagnostic clue for neuro-Behçet’s disease: the ‘cascade sign’
Jonathan Cleaver, Hamish Morrison, Shelley A Renowden, Denize Atan, Mark Cossburn, Claire M Rice
Cholesterol crystals in rheumatoid bursal fluid
Jing Zhu, Cong-Qiu Chu
Calcinosis and the cranium: inside and out
Kunal Chandwar, Prasanna Dogga, Kasturi Hazarika, Abilash Krishnan Vijaykumaran, Puneet Kumar
Improving nail involvement in systemic sclerosis: an overlooked sign in follow-up?
Hanlin Yin, Qingran Yan, Rui Li, Bei Liu, Liangjing Lu
Plant thorn synovitis: case report of a synovial biopsy both diagnostic and therapeutic
Catarina Tenazinha, Rita Barros, Joaquim Polido-Pereira, Fernando Saraiva
